Atlas Trials

Precigen Actobio T1D, LLC

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Precigen Actobio T1D, LLC

RecordFirmDate
A Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Combination With Teplizumab in Participants With Recent-onset Diagnosed Type 1 Diabetes (T1D) (NCT03751007)Precigen Actobio T1D, LLC2018-10-24

Track Precigen Actobio T1D, LLC automatically

Every clearance here is in the API, with alerts when new ones post.